Chimerix, Inc. ( CMRX) - Key Metrics
Stock symbol CMRX is outdated, potentially delisted? Maybe it is available on other exchange?
CMRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | $0 | -$0.25 | -$0.21 | -$0.22 |
| 2024Q3 | $0 | -$0.26 | -$0.23 | -$0.23 |
| 2024Q2 | $0 | -$0.23 | -$0.20 | -$0.20 |
| 2024Q1 | ? | -$0.25 | -$0.20 | -$0.20 |
| 2023Q4 | $0 | -$0.20 | -$0.16 | -$0.48 |
CMRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | ? | -3.42 |
| 2024Q3 | ? | -0.91 |
| 2024Q2 | ? | -0.94 |
| 2024Q1 | ? | -1.07 |
| 2023Q4 | ? | -1.18 |
CMRX
Price: $8.54
52 week price:
Earnings Per Share: -0.99 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 701000
Ebitda: -17.6 millionMarket Capitalization: 801.1 million